Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.8787
+0.104213.45%
Volume:2.99M
Turnover:2.51M
Market Cap:142.18M
PE:158.87
High:0.8900
Open:0.7786
Low:0.7501
Close:0.7745
Loading ...

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Business Wire
·
23 Apr

Ironwood Shares Tank on Regulatory Update for Apraglutide

Zacks
·
15 Apr

Ironwood Pharmaceuticals Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
15 Apr

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7

MT Newswires Live
·
15 Apr

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Reuters
·
15 Apr

Wells downgrades Ironwood to Equal Weight on ‘major setback’

TIPRANKS
·
15 Apr

Ironwood Pharmaceuticals Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
15 Apr

Top Midday Decliners

MT Newswires Live
·
15 Apr

Crude Oil Moves Lower; M&T Bank Earnings Miss Views

Benzinga
·
15 Apr

Ironwood Pharma Shares Fall on Word of Confirmatory Phase 3 Apraglutide Trial

Dow Jones
·
14 Apr

BRIEF-Ironwood Pharmaceuticals Provides Clinical And Regulatory Update On Apraglutide

Reuters
·
14 Apr

Ironwood Pharmaceuticals Inc - Engages Goldman Sachs to Explore Strategic Alternatives

THOMSON REUTERS
·
14 Apr

Ironwood Pharmaceuticals Inc - Requires Confirmatory Phase 3 Trial for Apraglutide Approval

THOMSON REUTERS
·
14 Apr

Ironwood Pharmaceuticals Inc - to Work With FDA on Confirmatory Phase 3 Trial Design

THOMSON REUTERS
·
14 Apr

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Business Wire
·
14 Apr

Ironwood Pharmaceuticals Gets Nasdaq Non-Compliance Notice

MT Newswires Live
·
28 Mar

Ironwood receives Nasdaq non-compliance notification

TIPRANKS
·
28 Mar

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Business Wire
·
28 Mar

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Zacks
·
25 Mar

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
03 Mar